Press Release

Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update

April 28, 2021 at 7:01 AM EDT

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, May 5, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the first quarter of 2021.

Conference Call & Webcast Details
Date: Wednesday, May 5, 2021 
Time: 8:00 am Eastern Time
Toll Free: (844) 348-3801
International: (213) 358-0955
Conference ID: 7587147

The live webcast of the conference call can also be accessed in the Investors section of Editas Medicine website at

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit

Cristi Barnett
(617) 401-0113

Ron Moldaver
(617) 401-9052

Primary Logo

Source: Editas Medicine, Inc.